chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a 14 year old female consumer who in August 2009 was vaccinated with a first dose of GARDASIL. In August 2009 the consumer noticed that her hair was falling out a little. In October 2009 the consumer received a second dose of GARDASIL. In February 2010 the consumer received a third dose of GARDASIL and noticed a lot of hair loss. It was reported that about half of the consumer's hair was gone. The consumer saw a physician on 05-APR-2010 and had "bloodwork" done on 06-APR-2010, no results provided. At the time of the report, the consumer had not recovered. Follow-up information has been received from a physician concerning the 14 year old female patient, with no pertinent medical history and no known drug reactions or allergies, who on 13-JUL-2009, received intramuscularly the first 0.5 mL dose of GARDASIL (lot number 661954/1131X). On 15-SEP-2009 (previously reported as October 2009), the patient received intramuscularly the second 0.5 mL dose of GARDASIL (lot number 662300/1674X) and on 19-FEB-2010, the patient received intramuscularly the third dose of GARDASIL (lot number 662300/1674X). There was no concomitant therapy. The physician reported that the patient experienced hair loss and eyelash loss. The hair loss started around the time of the third dose (previously reported as August 2009) and was coming out in clumps. The patient had thinning of hair at the time of reporting. The physician stated that it was unknown if the hair was growing back. The physician stated that no eye irritation was noted but each morning she had 3-4 eyelashes that have fallen. The patient also had polydipsia. Blood tests were performed and the results were negative for diabetes (glucose) and thyroid. Blood test for chemistry panel was also performed and the results were not provided. At the time of reporting the patient had not recovered. Follow-up information has been received from a physician, who reported that the 13 year old (previously reported as 14 year old) female patient, received on 19-FEB-2010, the third dose of GARDASIL at around 14:00h. The physician reported that on 01-MAR-2010, the patient started to experience hair loss and fatigue for a month. No treatment was followed. The physician reported that the experienced required a doctor visit. There were ordered labs but the patient never completed them. The patient's outcome was unknown at the time of reporting. Additional information has been requested.
Taste in mouth. Could feel in lungs. Eyes watering. Teeth chattering.  Could not walk at first. When could walk needed help of two person to sit in observation area. After about 40 minuets was able to walk.  Felt like my heart was bouncing at times.  Legs were very weak. Headache the next day and nausea. My legs and balance are still off but I?m much better.   Notified md office on April 12, and 13th by phone and was told if not better by next Monday to call back then by the nurse that I did not need to be seen at this time.
Pt has several brief limp spells, brief stiffening. No loss of consciousness; sleeping afterward. Physician suspected seizures, but the pt has not had any since then.
Inbound call from office manager calling to report administration of VARIVAX that experienced a temperature excursion.  Confirmed with reporter that no symptomatic adverse effects were reported.   Affected product was administered to one additional p; No symptomatic adverse effects reported; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug allergies/reactions, or concomitant medications was not provided.  On 21-JUN-2023, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection at a dose of 0.5 milliliter once, for prophylaxis (route of administration, vaccination scheme frequency, and anatomical location were not reported; lot number W025274 with an expiration date of 10-AUG-2024). The administered dose of the vaccine experienced a temperature excursion of -13.2 degrees Celsius (C) for 58 minutes. No data logger was implied. There was no adverse effect reported.
This spontaneous case reported by a consumer, describes the occurrence of disturbance in attention (husband couldn't get wife's attention) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included cancer. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 5, 2021, patient experienced disturbance in attention (husband couldn't get wife's attention). At the time of the report, disturbance in attention (husband couldn't get wife's attention): unresolved. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
This case was reported by a consumer via interactive digital media and described the occurrence of heart rate increased in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced heart rate increased, fever and nausea. On an unknown date, the outcome of the heart rate increased, fever and nausea were not recovered/not resolved. It was unknown if the reporter considered the heart rate increased, fever and nausea to be related to SHINGRIX. Additional details were provided as follow: This case was reported by the patient's daughter via social media. The age at vaccination was not reported. The reporter posted a serious post and stated that; do not let your parents or grandparents get the new Shingles vaccine that was supposed to be more effective. SHINGRIX landed the reporter's friend's mother in emergency room with very elevated heart rate and pressure, fever and nausea. Two weeks later, the patient was feeling theses things from time to time. The reporter stated that, anything that messes up the heart was not worthy. The reporter contacted her friend and she confirmed that the patient took SHINGRIX.
Pt states that about 12 p rcring vaccine experienced pain/swelling under arm, down by side and in entire face. Denies respiratory distress but some swelling in mouth/nose that has resolved now. NO wheezing. DId not seek medical attention until 4/12/21. Denies Resp distress  Pt instructed to go home with family. No work, out of heat. Ice to face, area of swelling given samples of Zyrtec for qd Benadryl @ night DO NOT take 2nd COVID vaccine ER if s/s change/worsen/resp distress
Patient tested positive for COVID-19; patient had a cough and lost some sense of taste and smell
Started with acute onset fatigue and chills(at the same time,9pm). Spiked a 104.5 temp @ aprx 2 am. Went back and forth between chills/fever for 15 hours. Slept for 13 hours and felt fine when I woke up. Body Aches and headaches were also felt the whole time.
This literature report (initial receipt 10-Apr-2012) concerns a 61 year-old male patient. The patient had no clinical or laboratory evidence suggestive of any precipitating conditions. In 2010/2011 the patient received H1N1 (manufacturer is unknown). 1 week after receiving H1N1 the patient developed his first symptom of Guillain-Barre syndrome (GBS). Sensory symptoms included hand and feet numbness and parascapular pain. Motor symptoms included weakness and gait disturbance. A neurological examination revealed proximal weakness (4+/5) in all extremities, absent vibration and joint position at bilateral toes and ankles, reduced pin-prick and light touch at bilateral feet and hands, severe sensory ataxia, generalised loss of deep tendon reflex and positive Romberg sign. The patient's cerebrospinal fluid (CSF) protein was 58mg/dl which was considered elevated. 15 days after receiving H1N1 electrodiagnostic findings revealed sural sparing, prolonged distal latencies and absent F responses which were highly suggestive of acute inflammatory demyelinating polyneuropathy (AIDP). Clinical history, neurological exam, imaging studies, and serological and CEF markers excluded other etiologies of acute neuropathy such as vasculitis, vitamin deficiency, toxic neuropathy and porphyria. Treatment included intravenous immunoglobulin (IVIG) 0.4kg/day for 5 days. At time of discharge from hospital or rehabilitation facility the patient's gait, balance, vibration and joint position improved rapidly. The numbness in his hands and feet continued for a longer duration. The patient reached close to his baseline level activities by 6 months. Reporters comment: Clinical history, serological studies and CSF findings did not point to any other precipitating conditions except for the H1N1-influenza vaccination. The Brighton Collaborative Working Group established criteria for GBS in association with vaccine. The patient did not have one of the diagnostic certainty criteria recommended by the working group however the working group recognised that their case definitions might not include some rare and atypical clinical variants of GBS. A relationship between the vaccine and GBS was not necessarily established.
Pt showed up to the ER via EMS on 6/5/2021 with low back pain and weakness, bilateral leg swelling, shortness of breath.  On 6/6/2021-developed bilateral upper and lower weakness that progressed to dysphagia and dysphonia. Transferred to ER on 6/8/2021 for Gillian Barre Syndrome  On 6/11  had bilateral DVTS He was placed on palliative care and passed away on 6/19/2021
A spontaneous report with was received on 26OCT2017 from a male consumer. Additional information was received in the form of the completed Adverse Event Data Collection Form and medical records on 01NOV2017. A 35 year-old patient reported that he received BIOTHRAX, "the full series, in 2002-2005, and then again after my medical record was lost in 2006, and then again after my medical record was lost in 2009." "I was given/forced the initial dose of Anthrax in 2002, 2006, 2009." My records "indicate that I was given more than the recommended dose on several occasions". He inquired about the overuse of the Anthrax Vaccine and the "possible" health consequences. From the "incomplete" vaccination record shared by the consumer: 03JAN2003, third dose, FAV066, 17SEP2003, fourth dose, FAV066, 30MAY2007, third dose, FAV103, 12APR2009, second dose, FAV177, 20NOV2009, fifth dose, FAV217. The consumer reported the following adverse events were facing him at the time of the report or in the past. He reports Fatty Liver Disease identified when gallbladder was removed 8/2016, Barrett's Esophagus without dysplasia identified on EGD 9/28/2016, Celiac Disease diagnosed by biopsy on 9/28/2016 and Gallbladder removal 8/2016 with pathology report indicating Mild Benign Papillary Epithelial Hyperplasia. Fibromyalgia was diagnosed 1/14/2016. He additionally reports Joint Pain, Chronic Fatigue, PTSD, TBI, Depressive Disorder, Moderate Osteoarthritis right knee, Osteoarthritis Bilateral Hips, Osteoarthritis Lower Back, Feet Problems, Throat swelling, Chronic Otomastoiditis, Painful urination, Sexual dysfunction, and Chronic Diarrhea. He reports Chronic kidney stones and had a CT 9/2014 revealing punctate nonobstructing calcifications bilat perinephric fat stranding - poss inflammatory changes related to pyelonephritis, Kidney infection. He reports Rhabdomyolysis at some time in the years after immunization, though medical records indicate diagnosis was in 2001 after 7 days of working out in a row. On 10/20/2017 he experienced a Seizure after playing with PlayDoh; subject assumes this was related to his gluten allergies as PlayDoh contains wheat. The subject additionally self-reports a right shoulder injury - slap tear, torn biceps tendon, and torn rotator cuff. The consumer added in his update to the Adverse Event Data Collection Form that the onset of the reported adverse events was "2004?". The individual onset date for each medical complaint noted in the medical records was recorded when available. Allergies: Penicillin, sulfa drugs, KEFLEX, BIAXIN, clindamycin, PAXIL, WELLBUTRIN, nicotine and glutens. Active medication list:  cholestyramine, cyclobenzaprine, lansoprazole, methylphenidate, naproxen, nicotine gum, pregabalin, marijuana. Additional medical records available upon request. Compete immunization record has been requested.
I just feel it may warrant further in estigation. Viral gastric enteritis presenting as small bowel obstruction. Sbo are usually fibrous adhesions. 3 people I have heard of had had these viral induced. Never heard of it before this year. How about a young man that at 21.got a terrible kidney infection recently. Let's  be clear I would still get the vaccine. That was a nephew and my brother died a week after getting vaccination and chemo 2 days apart
Vaccine was on Thursday morning and then on Saturday night started extreme itching of both palms and then woke up this morning (Monday) with hives all over my arms and legs.  In addition last evening (Sunday) I started having pretty intense pain in my lower back left side.  About in the hip/back area.
Information has been received from a certified medical assistant referring to unspecified patients of unknown age and gender. On unknown dates, the patients received doses of improperly stored (Oka/Merck) VARIVAX (batch/lot number # L019999, expiration date 02-JUN-2017, batch/lot number # L035127, expiration date 14-SEP-2017, batch/lot number # L046885, expiration date 23-NOV-2017, batch/lot number # M006729, expiration date 05-FEB-2018, dose and route not provided). No adverse reactions were reported. There was no product quality issue (PQC) involved. This is one of several reports received from the same source. Additional information has been requested.
INJECTION SIDE REDNESS, WIDE SPEARD HIVES, AND ICHYNESS
headache, nonproductive cough, loss of taste, loss of smell, ear pain, , sinus congestion, nasal congestion, chest tightness, sneezing, ear fullness. starting on 11/6/21
She got her vaccine, her arm was still hurting after about a week, and started hurting more and more.  It started locking on her and swelled up.  She went to her PCP about a week after the vaccine and told her that there was something wrong with her shoulder.  She sent her to have an x-ray done and it was normal.  She then had an US and stated that it showed something.  She then had an MRI which showed a torn rotator cuff, fluid in her arm and the muscle was messed up.  She was sent to hospital to an orthopedist and had therapy and that she was wasting her time as they did not know what was wrong with her.  She went back to her PCP and she was then sent to an Orthopedist.  He gave her a steroid injection to see how her arm felt.  She returned and it continued to hurt and she was informed that it was torn real bad and that she needed to have surgery.  She was scheduled for surgery on 6/28/22 at Hospital and has been going to therapy to get her motion back.  She is in a lot of pain, and crying with it, also having depression due to her situation.
I have gradually developed oral Thrust since my vaccine. I am questioning if this could be related to my vaccine. Today my mouth and tongue are the sorest. I have gotten oral thrush from an antibiotic in the past year and had to discontinue the course. My questions.. Could this be due to the vaccine?. If so, how do I treat it? How do I decide if my second dose will be okay to take?
Patient nauseous, vomited and anxious.  Patient vitals-BP(120/70), HR(81), Resp 16.  Vitals are stable and patient will be transferred via ambulance to hospital with mom.
she became sick with the hives; extreme hives; rash outbreak; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 10 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 11Dec2021 (Lot number: FC0007) at the age of 10 years as dose 1 (tris), single for covid-19 immunisation. Relevant medical history included: "Asthma" (ongoing). Concomitant medication(s) included: ALBUTEROL HFA taken for asthma; FLOVENT taken for asthma. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "she became sick with the hives"; URTICARIA (non-serious), outcome "unknown", described as "extreme hives"; RASH (non-serious), outcome "unknown", described as "rash outbreak". The events "she became sick with the hives", "extreme hives" and "rash outbreak" were evaluated at the physician office visit.  Additional information: The patient received the vaccine in early afternoon. The reporter stated that she was now having since in the last month some extreme hives and rash outbreak which did not 'itch' and the reporter sent her to her doctor twice in the last 3 weeks and they didn't know, understood where it was coming from and they were not going to change in any upper environment. Expiration date of Covid19 vaccine was reported as 11-21. On first day, the patient was put on Zertec, then was the breakthrough Benadryl and then it was breakthrough eruptions of the hives and they put her on prednisone. Prednisone expiration date was 15Jan2023, LOT# 108231003516, 5 mg, tablet. LOT# for Cetrazine was 108231001520/ HK1170 expiration date was Jan2023/ Jun2023. For asthma the patient also had 'zentol'.  Follow-up attempts are completed. No further information is expected.
After receiving the vaccine i had the standard sore and tenderness of my arm. That night I had severe chills and fever and I was just feeling extremely sick. I felt as if I had covid all over again for about 3 days after receiving the vaccine. In the middle of the night on a random night actually for the first time i experienced vertigo. I felt as if my head exploded off my body, and everything was moving so fast. I felt as if i almost wet myself, I felt as if I was almost falling off the bed, and almost every time i moved i felt horrible. I called my doctor and they prescribed me something through a telehealth that didn't really help. Later they prescribed me some steroids I don't remember the name of them but they helped a little but i've been experiencing that on and off for a while but they are not as harsh as they were.
within 3 hours of when I took the shot my neck was stiff and was painful.  I also had a rash on my chest and neck.  The neck was not back to normal for approx 4 days and itch continued for 3 or 4 days.
Kinrix administered to a 4 month old infant; This case was reported by a physician via patient support programs and described the occurrence of inappropriate age at vaccine administration in a 4-month-old patient who received DTPa-IPV (Kinrix) (batch number d24g7, expiry date unknown) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-MAY-2022 Reporters comment: Kinrix was administered to a 4-month-old patient on accident. Doctor stated that, they noticed after and the patient was in office doing a checkup at the time of reporting. The reporter wanted to know the difference between Kinrix and another vaccine that was not theirs and gave the patient's parents more information. The call center representative placed the reporter on hold so he/she could get additional product adverse events information and they discontinued the call. Additional supportive information: Kinrix was administered to a 4-month-old patient on accident, which led to inappropriate age at vaccine administration.
Immediately getting the shot, my whole arm was extremely painful. I had difficulty sleeping that night, and my arm was a little swollen.  The person gave me a flu shot the prior week and everything was perfect!  Also had a bad headache.  It is much better two days later - just a little sore.
Information has been received from a licensed practical nurse concerning an approximately 30 month old patient who on 11-OCT-2005 was vaccinated with a dose of VARIVAX (Merck). On approximately 20-APR-2007, the patient experienced varicella. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
pt recv vax;exp possible breakthrough chicken pox according to pt's mom w/ about 25 pruritic pox concentrated on back, scalp, and around face; pt was not seen by MD & subsequently recovered;
This spontaneous report as received from a nurse practitioner refers to a patients of unknown age and gender. Patient's medical history and current conditions were not provided. On an unknown date the patients were vaccinated with a dose of improperly stored PEDVAXHIB (lot #, expiration date, dose and route were not reported). No concomitant medications were reported. Additional information has been requested. This is one of several reports received from the same reporter.
11 year old female received a adult Pfizer vaccine.  Follow-up telephone call to parent, she reported that she was fine except for a sore arm at the injection site.
This is a literature report for the following literature source(s): A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history included: "Solid organ transplant recipients" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "only 1 patient tested positive for COVID-19 after the first dose". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive. The reporter considered "only 1 patient tested positive for Covid-19 after the first dose" related to BNT162b2. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Sender's Comments: Based on the information currently available, a lack of efficacy with bnt162b2 vaccine in this patient cannot be completely excluded.
Patient received Dtap and MMR in left arm on 11-12-03 area is swollen, bright red and warm to touch.  Area measures 6" x 3". Has not had any fever.
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapy were not provided. Since 10-NOV-2016, the patients were vaccinated with improperly stored doses of GARDASIL 9 (lots # L011846 exp date 16-JUN-2017, L026602 exp date 19-OCT-2017 and L036301 exp date 20-DEC-2017 (dose and route not reported) for prophylaxis. The vaccines were exposed to 33.8 Fahrenheit degrees for 1 hour 25 minutes. The call was placed because of a Digital data logger. No adverse experiences were reported. As of 06-FEB-2017, all telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1612USA001949: US-009507513-1612USA001951: US-009507513-1612USA001952: US-009507513-1611USA009104.
Fatigue,muscle and joint aches started 1-2 days after vaccination. Lasted 24-48 hrs
pt recv vax;woke up in am w/ light blotches on back,legs;disappeared & came back;lt thigh became very swollen;to er;4 doses of dph for 1 day given;MD does not believe hives due to vax;dermatrop given,stopped dph;